Abstract:Background: Infiltration by macrophages (M phi) indicates a poor prognosis in breast cancers, in particular by inducing angiogenesis. Our study aimed 1) to investigate the mechanism by which cooperation between M phi and aggressive breast cancer cells (MDA-MB-231) induces angiogenesis; 2) to examine the effect of tetrathiomolybdate (TM) on this angiogenic activity.Methods: M phi coincubated with MDA-MB-231 were used as a model to mimic the inflammatory microenvironment. Angiogenesis induced by the culture media was tested in the chick chorioallantoic membrane (CAM). M phi phenotype was evaluated by 1) expression of the M1 marker CD80, and secretion of interleukin 10 (IL-10), an M2 marker; 2) capacity to secrete Tumour Necrosis Factor alpha (TNF alpha) when stimulated by lipopolysaccharide/interferon gamma (LPS/IFN gamma); 3) ability to induce MDA-MB-231 apoptosis. To explore the molecular mechanisms involved, cytokine profiles of conditioned media from MDA-MB-231, M phi and the coculture were characterised by an antibody cytokine array. All experiments were carried out both in presence and in absence of TM.Results: Incubation of M phi with MDA-MB-231 induced a pro-angiogenic effect in the CAM. It emerged that the angiogenic activity of the coculture is due to the capacity of M phi to switch from M1 M phi towards M2, probably due to an increase in Macrophage Colony Stimulating Factor. This M1-M2 switch was shown by a decreased expression of CD80 upon LPS/IFN gamma stimulation, an increased secretion of IL-10, a decreased secretion of TNF alpha in response to LPS/IFN gamma and an inability to potentiate apoptosis. At the molecular level, the angiogenic activity of the coculture medium can be explained by the secretion of CXC chemokines/ELR(+) and CC chemokines. Although TM did not modify either the M2 phenotype in the coculture or the profile of the secreted chemokines, it did decrease the angiogenic activity of the coculture medium, suggesting that TM inhibited angiogenic activity by interfering with the endothelial cell signalling induced by these chemokines.Conclusions: Cooperation between M phi and MDA-MB-231 transformed M1 M phi to an angiogenic, M2 phenotype, attested by secretion of CXC chemokines/ELR(+) and CC chemokines. TM inhibited this coculture-induced increase in angiogenic activity, without affecting either M phi phenotype or cytokine secretion profiles.

Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model

The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo

Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer

CXCL4 and CXCL4L1 in cancer

Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer

The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer

Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy.

CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients

Ginsenoside Rg3 Inhibits CXCR4 Expression and Related Migrations in a Breast Cancer Cell Line.

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors

Predictive markers of efficacy for an angiopoietin-2 targeting therapeutic in xenograft models

LYG-202 Inhibits Activation of Endothelial Cells and Angiogenesis Through CXCL12/CXCR7 Pathway in Breast Cancer

Effects of CXCL4 on human dermal microvascular endothelial cells and secretion of vasomotion factors

A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities

Monocyte Chemoattractant Protein 1 and Fractalkine Play Opposite Roles in Angiogenesis Via Recruitment of Different Macrophage Subtypes.

Stimulation of Angiogenesis Resulting from Cooperation Between Macrophages and MDA-MB-231 Breast Cancer Cells: Proposed Molecular Mechanism and Effect of Tetrathiomolybdate

Data from Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody

In Vivo and in Vitro Studies of Blocking CXC Chemokine Receptor-4 on Bone Metastasis of Breast Cancer